CaseTrail

Merck Kgaa v. Integra Lifesciences I, Ltd.

545 U.S. 193 · Decided June 13, 2005 · Supreme Court of the United States

Record summary. This page is generated from the Supreme Court Database’s coded data about the case. It describes who decided what, not the Court’s reasoning. Read the opinion itself before relying on it. Not legal advice.

At a glance

Merck Kgaa v. Integra Lifesciences I, Ltd. was decided on June 13, 2005 unanimously (9–0). The Court vacated the lower court's decision and remanded the case. Justice Antonin Scalia wrote the opinion of the Court. SCDB classifies its main issue as “Patents” in the Economic Activity area.

Read the opinion

Case details

Citations
545 U.S. 193 · 125 S. Ct. 2372 · 162 L. Ed. 2d 160 · 2005 U.S. LEXIS 4840
Docket number
03-1237
Decided
June 13, 2005
Argued
April 20, 2005
Decision type
Opinion of the Court (orally argued)
Disposition
Vacated and remanded
Outcome for petitioner
The petitioning party received a favorable disposition
Vote
9–0 (unanimous)
Majority opinion
Antonin Scalia
Opinion assigned by
William H. Rehnquist
How the case arrived
Certiorari
Issue (SCDB)
Patents
Legal provision
35 U.S.C. § 271
Type of law
Infrequently litigated statute
Decision direction (SCDB)
Liberal what this means

How the Justices voted

Full case caption

Merck Kgaa v. Integra Lifesciences I, Ltd., et al.

SCDB identifiers: case 2004-059, docket 2004-059-01.

Other cases on “Patents”

See all

Cases on the same legal provision: 35 U.S.C. § 271

Same Term, same area (Economic Activity)

See all

Source: Supreme Court Database, 2026 Release 01 (data file dated September 8, 2026). Imported into CaseTrail November 5, 2026. Coverage: decisions from the 1946 through 2025 Terms. Methodology · Report an error